Cohort of Patients With a Symptomatic Rotator Cuff Tear Treated Without Surgical Repair

NCT ID: NCT02510352

Last Updated: 2015-07-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-04-30

Study Completion Date

2014-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In accordance with national guidelines surgical repair of rotator cuff tear is the first-line strategy only in young patients, depending on tear size, fatty infiltration of rotator cuff muscles and articular status. In appropriate situations, a satisfactory result is expected in more than 80% of cases with a very good long-term outcome. On the other hand, the first-line strategy in older patients is conservative as the main objective is the treatment of pain and stiffness of the shoulder which can be achieved at least in the short-term with general and local medications and physiotherapy. In addition, poor prognostic factors such as massive tears and muscle fatty infiltration or atrophy, are more frequently present in those patients, leading to poor results of surgical treatment and a high risk of iterative tear after repair.

Because of a lack of evaluation, there is currently no identified prognostic factor of medical treatment and on the other hand no clinical situation in which a surgical repair is mandatory. Therefore, investigator designed this study as an observatory with the follow up of patients with a symptomatic rotator cuff tear treated conservatively.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients are regularly monitored in rheumatology consultation at 3 months, 6 months, 1 year, 2 years, 30 months, 3 Years, 42 months, 4 years, 54 months and 5 years supplemented by simple radiological monitoring and an MRI followed by 1 year, 2 years and 5 years.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rotator Cuff Tear

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Rotator cuff tear

patients with a symptomatic rotator cuff tear treated without surgical repair

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having a clinical symptoms suggesting a rotator cuff tear.
* Having a full-thickness tear of the rotator cuff confirmed by MRI.
* Covered by the Social Security system.

Exclusion Criteria

* Being included in another clinical trial with a potential alteration of shoulder pathology management.
* Having a partial tear of the rotator cuff.
* Having a single lesion of the bicipital tendon.
* Having a traumatic tear of the rotator cuff less than 3-month old.
* Having surgery for rotator cuff tear planned within 3 months.
* Unable to understand the study protocol.
* Having a contra-indication to MRI.
Minimum Eligible Age

50 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Saint Etienne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thierry Thomas, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Universitaire de Saint Etienne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hopital Ambroise Pare

Boulogne-Billancourt, , France

Site Status

Centre de Rhumatologie

Grenoble, , France

Site Status

Clinique Orthocèdres

Grenoble, , France

Site Status

Hopital Corentin-Celton

Issy-les-Moulineaux, , France

Site Status

Clinique Du Parc

Lyon, , France

Site Status

Centre Orthopedique Santy

Lyon, , France

Site Status

Cabinet de Rhumatologie

Marseille, , France

Site Status

Hopital Lariboisiere

Paris, , France

Site Status

Hopital Cochin

Paris, , France

Site Status

Chu de Saint Etienne

Saint-Etienne, , France

Site Status

Chu de Strasbourg

Strasbourg, , France

Site Status

Chu de Tours

Tours, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DGOS

Identifier Type: OTHER

Identifier Source: secondary_id

0501079

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.